Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christophe Pannecouque

Showing results (141-150 of 427) with videos related to

Pageof 43
Sort By:
Journal of the American Chemical Society|April 7, 2005
Deoxythreosyl phosphonate nucleosides as selective anti-HIV agentsTongfei Wu, Matheus Froeyen, Veerle Kempeneers, et al.
Chemmedchem|May 8, 2013
Discovery of piperidine-linked pyridine analogues as potent non-nucleoside HIV-1 reverse transcriptase inhibitorsXuwang Chen, Yuanyuan Li, Shufang Ding, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|June 24, 2014
Design and synthesis of a new series of cyclopropylamino-linking diarylpyrimidines as HIV non-nucleoside reverse transcriptase inhibitorsYang Liu, Ge Meng, Aqun Zheng, et al.
Chemical Biology & Drug Design|November 1, 2014
Design, Synthesis, and Anti-HIV Evaluation of Novel Triazine Derivatives Targeting the Entrance Channel of the NNRTI Binding PocketXuwang Chen, Qing Meng, Liyun Qiu, et al.
Journal of Medicinal Chemistry|March 8, 2002
Synthesis of new covalently bound kappa-carrageenan-AZT conjugates with improved anti-HIV activitiesPatrick Vlieghe, Thierry Clerc, Christophe Pannecouque, et al.
Chemical Biology & Drug Design|July 30, 2020
Design, synthesis, and biological evaluation of piperidinyl-substituted [1,2,4]triazolo[1,5-a]pyrimidine derivatives as potential anti-HIV-1 agents with reduced cytotoxicityBoshi Huang, Dongwei Kang, Ye Tian, et al.
Medicinal Research Reviews|August 27, 2024
Deciphering the enigmas of non-nucleoside reverse transcriptase inhibitors (NNRTIs): A medicinal chemistry expedition towards combating HIV drug resistanceKun Zhang, Yu-Jie Zhang, Min Li, et al.
Chemical Biology & Drug Design|March 22, 2024
Design and synthesis of Fsp<sup>3</sup>-enriched spirocyclic-substituted diarylpyrimidine derivatives as novel HIV-1 NNRTIsZihao Sang, Tao Zhang, Zhao Wang, et al.
Antimicrobial Agents and Chemotherapy|September 2, 2009
The phthalocyanine prototype derivative Alcian Blue is the first synthetic agent with selective anti-human immunodeficiency virus activity due to its gp120 glycan-binding potentialKatrien O François, Christophe Pannecouque, Joeri Auwerx, et al.
European Journal of Medicinal Chemistry|May 28, 2013
Molecular design, synthesis and biological evaluation of BP-O-DAPY and O-DAPY derivatives as non-nucleoside HIV-1 reverse transcriptase inhibitorsShiqiong Yang, Christophe Pannecouque, Dirk Daelemans, et al.
Pageof 43

Showing results (141-150 of 427) with videos related to

Sort By:
Pageof 43
Journal of the American Chemical Society|April 7, 2005
Deoxythreosyl phosphonate nucleosides as selective anti-HIV agentsTongfei Wu, Matheus Froeyen, Veerle Kempeneers, et al.
Chemmedchem|May 8, 2013
Discovery of piperidine-linked pyridine analogues as potent non-nucleoside HIV-1 reverse transcriptase inhibitorsXuwang Chen, Yuanyuan Li, Shufang Ding, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|June 24, 2014
Design and synthesis of a new series of cyclopropylamino-linking diarylpyrimidines as HIV non-nucleoside reverse transcriptase inhibitorsYang Liu, Ge Meng, Aqun Zheng, et al.
Chemical Biology & Drug Design|November 1, 2014
Design, Synthesis, and Anti-HIV Evaluation of Novel Triazine Derivatives Targeting the Entrance Channel of the NNRTI Binding PocketXuwang Chen, Qing Meng, Liyun Qiu, et al.
Journal of Medicinal Chemistry|March 8, 2002
Synthesis of new covalently bound kappa-carrageenan-AZT conjugates with improved anti-HIV activitiesPatrick Vlieghe, Thierry Clerc, Christophe Pannecouque, et al.
Chemical Biology & Drug Design|July 30, 2020
Design, synthesis, and biological evaluation of piperidinyl-substituted [1,2,4]triazolo[1,5-a]pyrimidine derivatives as potential anti-HIV-1 agents with reduced cytotoxicityBoshi Huang, Dongwei Kang, Ye Tian, et al.
Medicinal Research Reviews|August 27, 2024
Deciphering the enigmas of non-nucleoside reverse transcriptase inhibitors (NNRTIs): A medicinal chemistry expedition towards combating HIV drug resistanceKun Zhang, Yu-Jie Zhang, Min Li, et al.
Chemical Biology & Drug Design|March 22, 2024
Design and synthesis of Fsp<sup>3</sup>-enriched spirocyclic-substituted diarylpyrimidine derivatives as novel HIV-1 NNRTIsZihao Sang, Tao Zhang, Zhao Wang, et al.
Antimicrobial Agents and Chemotherapy|September 2, 2009
The phthalocyanine prototype derivative Alcian Blue is the first synthetic agent with selective anti-human immunodeficiency virus activity due to its gp120 glycan-binding potentialKatrien O François, Christophe Pannecouque, Joeri Auwerx, et al.
European Journal of Medicinal Chemistry|May 28, 2013
Molecular design, synthesis and biological evaluation of BP-O-DAPY and O-DAPY derivatives as non-nucleoside HIV-1 reverse transcriptase inhibitorsShiqiong Yang, Christophe Pannecouque, Dirk Daelemans, et al.
Pageof 43